News | March 14, 2023
Alpla and Inden pharma form joint venture
ALPLA is expanding its presence in the global market for pharmaceutical packaging by establishing a joint venture with Inden Pharma
ALPLA is expanding its presence in the global market for pharmaceutical packaging by establishing a joint venture with Inden Pharma
The company will be submitting the responses to US FDA observations within stipulated timeline
The inspection concluded with no observations
Time to combine innovation, access and technology to deliver positive patient outcomes
Company will invest in capacity increases, technological capabilities and long-term partnerships with key pharmaceutical and biotech companies
The agreement is for USFDA approved Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets
New GMP facility for clinical and small-scale commercial pharmaceutical lipids
The approved product is indicated for the treatment of adult patients with Multiple myeloma, in combination with Dexamethasone
Digital success is contingent on the way a company organizes itself around technology
The common stock of Concert will no longer be listed for trading on the Nasdaq Global Market
Subscribe To Our Newsletter & Stay Updated
